Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34.7M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
22.3M
-
Shares change
-
-592K
-
Total reported value, excl. options
-
$153M
-
Value change
-
-$7.2M
-
Put/Call ratio
-
0.42
-
Number of buys
-
44
-
Number of sells
-
-24
-
Price
-
$6.87
Significant Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q2 2024
99 filings reported holding IGMS - IGM Biosciences, Inc. - Common Stock, par value $0.01 per share as of Q2 2024.
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
of 34.7M outstanding shares and own 64.11% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.08M shares), Artal Group S.A. (3.33M shares), Redmile Group, LLC (3.07M shares), GOLDMAN SACHS GROUP INC (1.33M shares), BlackRock Inc. (883K shares), VANGUARD GROUP INC (879K shares), FMR LLC (819K shares), STATE STREET CORP (458K shares), and MILLENNIUM MANAGEMENT LLC (391K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.